1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by mRNA Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global mRNA Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Standardization Of Cancer Treatment MRNA Vaccine
1.4.3 Individualized Cancer Treatment MRNA Vaccine
1.4.4 Infectious Disease Treatment MRNA Vaccine
1.4.5 Infection Prevention MRNA Vaccine
1.5 Market by Application
1.5.1 Global mRNA Vaccine Market Share by Application: 2021-2026
1.5.2 Infectious Disease
1.5.3 Cancer
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global mRNA Vaccine Market
1.8.1 Global mRNA Vaccine Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global mRNA Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global mRNA Vaccine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global mRNA Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers mRNA Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global mRNA Vaccine Sales Volume Market Share by Region (2015-2020)
3.2 Global mRNA Vaccine Sales Revenue Market Share by Region (2015-2020)
3.3 North America mRNA Vaccine Sales Volume
3.3.1 North America mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.3.2 North America mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia mRNA Vaccine Sales Volume
3.4.1 East Asia mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe mRNA Vaccine Sales Volume (2015-2020)
3.5.1 Europe mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.5.2 Europe mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia mRNA Vaccine Sales Volume (2015-2020)
3.6.1 South Asia mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia mRNA Vaccine Sales Volume (2015-2020)
3.7.1 Southeast Asia mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East mRNA Vaccine Sales Volume (2015-2020)
3.8.1 Middle East mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa mRNA Vaccine Sales Volume (2015-2020)
3.9.1 Africa mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.9.2 Africa mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania mRNA Vaccine Sales Volume (2015-2020)
3.10.1 Oceania mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America mRNA Vaccine Sales Volume (2015-2020)
3.11.1 South America mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.11.2 South America mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World mRNA Vaccine Sales Volume (2015-2020)
3.12.1 Rest of the World mRNA Vaccine Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World mRNA Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America mRNA Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia mRNA Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe mRNA Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia mRNA Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia mRNA Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East mRNA Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa mRNA Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania mRNA Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America mRNA Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World mRNA Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global mRNA Vaccine Sales Volume Market Share by Type (2015-2020)
14.2 Global mRNA Vaccine Sales Revenue Market Share by Type (2015-2020)
14.3 Global mRNA Vaccine Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global mRNA Vaccine Consumption Volume by Application (2015-2020)
15.2 Global mRNA Vaccine Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in mRNA Vaccine Business
16.1 Moderna Therapeutics
16.1.1 Moderna Therapeutics Company Profile
16.1.2 Moderna Therapeutics mRNA Vaccine Product Specification
16.1.3 Moderna Therapeutics mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 eTheRNA
16.2.1 eTheRNA Company Profile
16.2.2 eTheRNA mRNA Vaccine Product Specification
16.2.3 eTheRNA mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 BioNTech
16.3.1 BioNTech Company Profile
16.3.2 BioNTech mRNA Vaccine Product Specification
16.3.3 BioNTech mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 CureVac
16.4.1 CureVac Company Profile
16.4.2 CureVac mRNA Vaccine Product Specification
16.4.3 CureVac mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 In-Cell-Art
16.5.1 In-Cell-Art Company Profile
16.5.2 In-Cell-Art mRNA Vaccine Product Specification
16.5.3 In-Cell-Art mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Translate Bio
16.6.1 Translate Bio Company Profile
16.6.2 Translate Bio mRNA Vaccine Product Specification
16.6.3 Translate Bio mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Tiba Biotechnology
16.7.1 Tiba Biotechnology Company Profile
16.7.2 Tiba Biotechnology mRNA Vaccine Product Specification
16.7.3 Tiba Biotechnology mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Argos Therapeutics
16.8.1 Argos Therapeutics Company Profile
16.8.2 Argos Therapeutics mRNA Vaccine Product Specification
16.8.3 Argos Therapeutics mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Sangamo Therapeutics
16.9.1 Sangamo Therapeutics Company Profile
16.9.2 Sangamo Therapeutics mRNA Vaccine Product Specification
16.9.3 Sangamo Therapeutics mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Ethris
16.10.1 Ethris Company Profile
16.10.2 Ethris mRNA Vaccine Product Specification
16.10.3 Ethris mRNA Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 mRNA Vaccine Manufacturing Cost Analysis
17.1 mRNA Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of mRNA Vaccine
17.4 mRNA Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 mRNA Vaccine Distributors List
18.3 mRNA Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of mRNA Vaccine (2021-2026)
20.2 Global Forecasted Revenue of mRNA Vaccine (2021-2026)
20.3 Global Forecasted Price of mRNA Vaccine (2015-2026)
20.4 Global Forecasted Production of mRNA Vaccine by Region (2021-2026)
20.4.1 North America mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.2 East Asia mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.3 Europe mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.4 South Asia mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.6 Middle East mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.7 Africa mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.8 Oceania mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.9 South America mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World mRNA Vaccine Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of mRNA Vaccine by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of mRNA Vaccine by Country
21.2 East Asia Market Forecasted Consumption of mRNA Vaccine by Country
21.3 Europe Market Forecasted Consumption of mRNA Vaccine by Countriy
21.4 South Asia Forecasted Consumption of mRNA Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of mRNA Vaccine by Country
21.6 Middle East Forecasted Consumption of mRNA Vaccine by Country
21.7 Africa Forecasted Consumption of mRNA Vaccine by Country
21.8 Oceania Forecasted Consumption of mRNA Vaccine by Country
21.9 South America Forecasted Consumption of mRNA Vaccine by Country
21.10 Rest of the world Forecasted Consumption of mRNA Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer